Skip to content

Emergent Biosolutions EBS Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

AMP
Amphastar PharmaceuticalsAMPH
$71.5M+56.0%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
$3.98M-28.3%
Opko Health logo
Opko HealthOPK
$45.8M-4.2%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
4.7%+0.6pp
Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$22M-40.5%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$317.84M-21.1%

Other financials

Income statement

See full
Revenue$156.1M-29.7%
Gross profit$84.1M-37.1%
Operating income$10.5M-79.0%
Net income$6.8M-90.0%
EPS (diluted)$0.07-94.1%

Balance sheet

See full
Cash & equivalents$161.5M+5.7%
Total debt$584.6M-13.1%
Total equity$523.1M-5.4%
Total assets$1.3B-7.4%

Cash flow

See full
Operating cash flow-$33.8M-202%
CapEx$2.4M-33.3%
Free cash flow-$36.2M-145%

Valuation

See full
Market cap$411.74M+22.0%
Enterprise value$834.84M-2.6%
P/E3.6×
P/S0.6×+0.3×

Profitability

See full
Gross margin54.2%+19.0pp
Operating margin15%+10.3pp
Net margin9.6%+5.8pp
FCF margin20.8%

Returns & leverage

See full
Return on equity13.9%+8.1pp
Debt / equity1.1×-0.1×
Current ratio4.3×-2.0×

Where this comes from

Reported directly by Emergent Biosolutions in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.

The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Emergent Biosolutions's operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Emergent Biosolutions's operating lease ROU assets?
Emergent Biosolutions (EBS) reported operating lease ROU assets of 6.4% in Q1 2026.
How has Emergent Biosolutions's operating lease ROU assets changed year-over-year?
Emergent Biosolutions's operating lease ROU assets decreased by 3.0% year-over-year, from 6.6% to 6.4%.
What is the long-term trend for Emergent Biosolutions's operating lease ROU assets?
Over 5 years (2020 to 2025), Emergent Biosolutions's operating lease ROU assets has grown at a 9.7% compound annual growth rate (CAGR), from 4.1% to 6.5%.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.